LB62 Ofatumumab vs Teriflunomide in Relapsing Multiple Sclerosis: Analysis of No Evidence of Disease Activity (NEDA-3) from ASCLEPIOS I and II Trials

Hauser, Stephen L.; Bar-Or, Amit; Cohen, Jeffrey A.; Comi, Giancarlo; Correale, Jorge; Coyle, Patricia K.; Cross, Anne H.; de Seze, Jerome; Montalban, Xavier; Selmaj, Krzysztof; Wiendl, Heinz; Willi, Roman; Li, Bingbing; Häring, Dieter A.; Ramnathan, Krishnan; Merschhemke, Martin; Kappos, Ludwig

DSpace Principal
→
Neurología
→
Enfermedades Desmielinizantes
→
Enfermedades Desmielinizantes.pósters
→
Ver ítem
Políticas del Repositorio
Contacto y sugerencias

LB62 Ofatumumab vs Teriflunomide in Relapsing Multiple Sclerosis: Analysis of No Evidence of Disease Activity (NEDA-3) from ASCLEPIOS I and II Trials

Hauser, Stephen L.; Bar-Or, Amit; Cohen, Jeffrey A.; Comi, Giancarlo; Correale, Jorge; Coyle, Patricia K.; Cross, Anne H.; de Seze, Jerome; Montalban, Xavier; Selmaj, Krzysztof; Wiendl, Heinz; Willi, Roman; Li, Bingbing; Häring, Dieter A.; Ramnathan, Krishnan; Merschhemke, Martin; Kappos, Ludwig

URI: https://repositorio.fleni.org.ar/xmlui/handle/123456789/574
https://onlinelibrary.wiley.com/doi/10.1111/ene.14363

Fecha: 2020-05-27

Mostrar el registro completo del ítem